Your web browser doesn’t have the Flash Player v.18 plugin installed, so this Website can’t be properly viewed.
For full experience, please download the latest Flash plugin at Adobe.com.
Download Adobe Flash Player now.

GARDASIL®

Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine


Who Can Get HPV

HPV could happen to you

Find out what you can do to help prevent the transmission of HPV.

Anyone who is sexually active, male or female, can get HPV (human papillomavirus). If you’re having skin-to-skin contact with an infected person’s genitals, you could get HPVHPVHPV stands for human papillomavirus, a common virus that affects both females and males. There are more than 100 types of HPV and most often it does not cause any symptoms and goes away on its own. Others can cause diseases of the genital area.
See Full Glossary
at any time. When it comes to the transmission of HPV, the facts speak for themselves:

  • HPV is easily spread. Any contact with someone who has it puts you at risk.
  • About 75% of sexually active Canadians will have at least one HPV infection during their lifetimes. For most people the infection will clear on its own, but if it doesn’t, cervical cancer or genital warts can develop. Even if you already have a certain type of HPV, you could still be at risk for other types of HPV.
  • Anyone is at risk of developing an HPV infection.
  • One infected partner may be all it takes to get HPV.


IMPORTANT INFORMATION ABOUT GARDASIL®

In girls and women ages 9 to 45, GARDASIL® helps prevent infection caused by HPV types 6, 11, 16 and 18 and the following diseases associated with the HPV types included in the vaccine: cervical, vaginal, and vulvar cancers caused by HPV types 16 and 18; abnormal and precancerous vaginal and vulvar lesions, abnormal and precancerous cervical lesions as found in Pap tests, caused by types 6, 11, 16 and 18; and genital warts caused by types 6 and 11.

In girls and women ages 9 to 26, GARDASIL® also helps protect against anal cancer caused by HPV types 16 and 18, and abnormal and precancerous anal lesions caused by types 6, 11, 16 and 18.

In boys and men ages 9 to 26, GARDASIL® helps protect against infection caused by HPV types 6, 11, 16 and 18 and the following diseases associated with the HPV types included in the vaccine: anal cancer caused by HPV types 16 and 18, genital warts caused by types 6 and 11, and abnormal and precancerous anal lesions caused by types 6, 11, 16 and 18.

GARDASIL® helps prevent these diseases, but it does not treat them. And just like all vaccines, GARDASIL® may not fully protect everyone who gets it. GARDASIL® does not protect against all types of HPV. Duration of protection continues to be studied. GARDASIL® does not protect against other sexually transmitted infections.

Even if vaccinated with GARDASIL®, it is still important for women to continue having regular Pap tests. Recipients of GARDASIL® should not discontinue anal cancer screening if it has been recommended by a healthcare provider. Vaccination with GARDASIL® is not recommended during pregnancy.

Like all vaccines, GARDASIL® may cause some side effects. GARDASIL® has been shown to be generally well tolerated in adults and children as young as age 9. The most commonly reported side effects included pain, swelling, itching, bruising and redness where the shot was given, fever, nausea, dizziness, headache, vomiting and pain in extremity.

Fainting has been reported. Fainting can occur after vaccination, most commonly among adolescents and young adults. Although fainting episodes are uncommon, vaccinees should be observed for 15 minutes after they receive GARDASIL®.

Allergic reactions that may include difficulty breathing, wheezing (bronchospasm), hives, and rash have been reported.

These were not all the side effects reported. If you notice any unusual or severe symptoms after receiving GARDASIL®, contact your healthcare professional as soon as possible.

Information about GARDASIL® is provided in the Consumer Information. To retrieve this information you will be re-directed to a page within our main Merck Website, which contains the Consumer Information.

Click here to go to the Gardasil® Consumer Information.

To view PDF documents, you must have Adobe Acrobat Reader®

To view PDF documents, you must have Adobe Acrobat Reader® By clicking on this link, you will be leaving this site This link will take you to a site outside of Merck Canada Inc.

Merck does not review or control the content of any non-Merck site. Merck does not endorse and is not responsible for the accuracy, content, practices, or standards of any non-Merck site.
Proceed
installed on your computer.







This site is intended only for residents of Canada. This Website is for information purposes only.
® Merck Sharp & Dohme Corp. Used under license.

© 2016 Merck Canada Inc. All rights reserved.
VACC-1158121-0000 FE 2017